Metis TechBio jumps on Jiangsu Hengrui-tie up on AI formulation platform

Metis TechBio

03/08/2026 06:48

** Shares of Metis TechBio 7666.HK jump 9.3% in the second rising session to HK$11, their highest level since July 28
** Stock of AI-driven nanomaterial platform technologies developer on track for the biggest one-day pct gain since July 23 
** Metis said its independently developed AiTEM AI formulation innovation platform will be deployed at Jiangsu Hengrui Pharmaceuticals 1276.HK to enhance the efficiency of drug formulation development 
** This collaboration marks the continued external commercialisation of the NanoForge-powered AiTEM artificial intelligence formulation innovation platform, initiating the process of NanoForge empowering a new generation of intelligent research and development infrastructure - Metis
** Jiangsu Hengrui Hong Kong shares slip 1.9%, Shanghai-listed stock 600276.SS down 2.1%
** Since debut on May 13, Metis stock down 0.6% from the offer price of HK$10.50 apiece
** YTD, Hang Seng Biotech Index .HSBIO down 3.8%

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))